Metformin Suspension and Insulin Sensitivity

Summary

Metformin is an insulin sensitizing drug routinely used for the treatment of anovulatory patients with polycystic ovary syndrome (PCOS). To date, the metabolic effects of the long-term metformin administration are know but no data are available on the effects after its suspension. The purpose of this study is to evaluate the effects of metformin suspension on insulin sensitivity in PCOS patients.

Timeline

Start

2003-12

Primary completion

—

Completion

2006-04

Drugs

Indications